SPRAVATO® is derived from a compound historically used as an anesthetic, which has also shown benefits in treating depression. Recently, this compound earned FDA approval specifically for use as a nasal spray for individuals with treatment-resistant depression.
Treatment-Resistant Depression (TRD): For individuals who have not achieved sufficient symptom relief despite trying at least two other antidepressant therapies.
Major Depressive Disorder (MDD) with Acute Suicidal Ideation or Behavior: A prompt-acting treatment option for those experiencing intense depressive episodes with immediate safety concerns.
Unlike many antidepressants that require several weeks to show results, SPRAVATO® has demonstrated noticeable symptom improvement in as little as 24 hours in clinical studies.
SPRAVATO® has the potential to alter perception during the first two hours after administration, so it must be given in a clinic setting.
Treatment is done on an outpatient basis. Patients must arrange transportation in advance, as they cannot drive after treatment.
With the nasal spray, you self-administer three doses, spaced five minutes apart, under the supervision of trained staff. You will remain in the clinic in a calm, private setting for two hours of observation to ensure any potential side effects subside.
SPRAVATO® is used in combination with a traditional antidepressant. The goal is for SPRAVATO® to offer fast relief from depressive symptoms while the other medication begins to take effect.
Complete Mind Care was founded on the premise of providing full mental health support delivered by a team of expert professionals, in the comfort of a world-class facility local to you—so you can build a foundation for lasting recovery close to home. Plus 40+ additional insurance carriers accepted.
Don’t see your insurance listed? Call our office at 215-607-7250 or 215-918-7939 to verify coverage.
SPRAVATO® (esketamine) works differently than traditional antidepressants. While most antidepressants target serotonin, norepinephrine, or dopamine systems, SPRAVATO® acts on the glutamate system in the brain—specifically blocking NMDA receptors.
This mechanism is thought to help restore neural connections that may be impaired in depression. The medication is administered as a nasal spray under medical supervision and is designed for adults with treatment-resistant depression (those who haven’t responded adequately to at least two antidepressant treatments) or for adults with major depressive disorder with acute suicidal thoughts or actions.
We follow FDA guidance and use only approved therapies. While some clinics may use off-label ketamine, we focus exclusively on treatments backed by clinical research.
Healing is influenced by surroundings. Our clinic is designed with calming, thoughtful aesthetics to support your well-being throughout treatment.
If you’re already working with a therapist or psychiatrist, we ensure full coordination so all aspects of your care work in harmony.
We work with your insurance and handle all necessary paperwork.
Explore the inspiring journeys of individuals who have transformed their lives through the clinical use of SPRAVATO®. From overcoming obstacles to reaching significant milestones, these individuals share how SPRAVATO® treatment has been instrumental in reshaping their habits and creating lasting change. Discover real-life stories of success, motivation, and the powerful impact of building sustainable habits for a better life.
Over 3,000+ residents have used SPRAVATO® to elevate their lives.
Avoid driving until the following day after a good night’s rest.
Download our comprehensive PDF guides to learn about SPRAVATO®, its benefits, uses, and other important safety information.